Miranda BML, Huacuja RL, López PAL, Panduro CA

Language: Spanish
References: 32
Page: 64-70
PDF size: 227.53 Kb.

ABSTRACT

The interest in Complementary and Alternative Medicine (CAM) therapies, are continue increasing significantly all over the world. The purpose of this investigation, was to determine the frequency and the type of alternative medicine that is used in for liver disease treatments. It is well know that the cirrhosis, hepatitis and diabetes mellitus alters body physiology, metabolism and liver cytoarchitecture. In this pathophysiological state condition, oxidative processes and lipoperoxidation of cellular membranes are closely related. For that reason, the aim of the present work go over interaction between the cirrhosis, diabetes, steatohepatitis and their association with oxidative stress in liver diseases. The most representatives mono and poliphytotherapies applied to liver diseases are described in the present work; as well as the most principal molecules plants, that produce a strong hepatoprotective effect against peroxidations that appear in the liver illness. Patients under take it CAM with plants present real health benefits. The use CAM for liver diseases is variable in Europe (20% to 65%), United States (39%) and Mexico (85%). It was found that the main antioxidants active compounds are flavonoids, lignans and terpens; all of them are polihydroxifenols. It is possible to propose that other molecules that are contained in plants from other localities, present Sho- Saiko-to activities without toxicity or other adverse effects since it has been demostrated that plants from other different families have the same biological activity.

REFERENCES

1. Xolocotzi HE: El concepto de la etnobotánica. Colegio de Posgrados Chapingo México. En: Plantas medicinales de México. Departamento de Fitoleemia. Unidad de estudios etnobotánicos. Univ. Aut. De Chapingo. 1989. 29-34.

2. Puebla A.M, Huacuja L, Orozco G, Villaseñor M.M, Miranda M.L, Celis A, and Sandoval L. Cytotoxic and antitumour activity from Bursera fagaroides etanol extract in mice with L5178Y lynphoma. Phytotherapy Res, 12;545-548:1998.

3. Mangena T, Muyima NY. Comparative evaluation of the antitumoral activities of essential oils of Artemisa afra, Pteronia incana and Rosmarinus officinalis on selected bacteria and yeast strains. Lett Appl Microbiol 1999;28:291-96.

4. Scortichini R. Preliminary in vitro evaluation of the antimicrobial activity terpenes and terpenoids Towards. Erwinia amylovora. J Appl Bacteriol, 1991;71:109-112.

5. Outtara B, Simard RE, Holley RA. Antimicrobial activity of selected fatty acids and essential oils against six meat spoilage organisms. Intl J food microbial, 1997;37:155-162.

6. Chen T, Li J, Cao J. A new flavone isolated from Rhizoma smilacis Glabrae and the structural requirements of its derivates for preventing immunological hepatocyte damage. Planta Médica, 1999;65:56-59.

7. Amirghofran Z, Azadbakht M, Karimi HM. Evaluation of immunomodulatory effects of five herbal plants. J Ethnopharmacol, 2002;72:167-172.

8. Huacuja L, Puebla AM, Carranco A, Miranda ML, Merchant H, Reyes A, Guzmán A. Contraceptive effect on male rats after oral administratrion crude extract. Adv Contraceptive Delivery Sist, 1997;13:13-21.

9. Miranda ML, Puebla AM, Guzmán A, Huacuja L. Male rat infertility induction/spermatozoa and epididymal plasma abnormalities after oral administration of Kalanchoe gastonis bonnieri natural juice. Phytotherapy Res, 2003;17:315-319.

10. Shimizu I, Sho-saiko-to. Japanese herbal medicine for protection against hepatic fibrosis and carcinoma. J Gastrol & Hepatol, 2000;15S:D84-D90.

11. Detlef Schuppan, Ji-Dong Jia, Benno Brinkhaus, Eckhart GH. Herbal products for liver diseases: A therapeutic challenge for the new millennium. Hepatology, 1999;30:1099-1104.

12. Fogden E, Neuberger J. Alternative medicines and the liver. Liver Int, 2003;23:213-220.

13. Haas L, McClain C, Mariled G. Complementary and alternative medicine and gastrointestinal diseases. Curr Opinion in Gastroenterol, 2000;16(2):188-196.

14. Alarcón F.J, Roman R, Perez S, Aguilar A, Contreras C.C, Flores J.L. Study of the anti-hyperglycemic effect of plants used as antidiabetics. J Ethnopharmacol, 1998;61:101-110.

15. Vats V, Grover J.K, Rathi S.S. Evaluation of anti-hyperglycemic and hypoglicaemic effect of Trigonella foenum-graecum Linn, Ocimum sanctum Linn and Pterocarpus marsupium Linn in normal and alloxanized diabetic rats. J Ethnopharmacol, 2002;79:95-100.

16. Heinze G, Ontiveros M. La fitofarmacología como tratamiento alterno en psiquiatría. Salud Mental, 1998 Dic;21(6)33-42.

17. Márquez AC, Lara OF, Esquivel RB, Mata ER. Plantas Medicinales de México (II). UNAM, 1ra edición, 1999.

18. Romo de Vivar A. Productos naturales de la flora Mexicana. Editorial Limusa, 1ra edición, 1985.

19. Ernst E. The role of complementary and alternative medicine. BMJ, 2000;321:1133-1135.

20. Strader DB, Bacon BR, Lindsay KL, La Breque DR, Morgan T, Wright EC, Allen J, Khokar MF, Hoofnagle JH, Seeff LB. Use of complementary and alternative medicine in patients with liver disease. Am J Gastoenterol, 2002;97:2391-2391.

21. Diamond J. Close encounters of an alternative kind. BMJ, 2000;321:1163-1164.

22. Taddel GA, Santillán MA, Romero JA. Aceptación y uso de la herbolaria en medicina familiar. SPM, 1999;41:216-220.

23. Dobbins R, Szezepaniark, Bentley B etal. Prolonged inhibition of musele carnitine-palmitoltransferase-1 promotes intramyocellular lipid accumulation and insuline resistence in rats. Diabetes, 2001;50:123-129.

24. Leeks B, Houglum K. Activation of hepatic stellare cells by TGF-b and collagen tipe I ls by oxidative stress through c-myb expression. J Clin Invest, 1995;96:2461-8.

25. Symposium on complementary and alternative medicine in chronic liver disease. The National Institute of Health. August, 1999. 26. Amirghofran Z, Azadbakht M, Karimi MH. Evaluation of the immunomodulatory effects of five herbal plants. J Ethnopharmacol, 2000;72:167-172.

26. Kuklinsky C. Farmacognosia/Estudio de las drogas y sustancias medicamentos de origen natural. Ediciones Omega. Barcelona. 2000.

27. Matsunami H. Use of Glycyrrizhin for recurrence of hepatitis B after liver transplantation. Gastroenterol, 1993;88:152-153.

28. Borchers AT, Sakai H,. Sho Saiko to and Other Kampo (Japanese herbal) medicine: a review of the inmunomodulatory activities. J Ethnopharmacol, 2000;73:1-13.

29. Ohtsuka M, Fukuda K, Kojiro M. Effects of nine active ingredients in Chinese Herbal Medicine Sho Saiko to on 2 –(2-furyl)-3-(nitro-2-furyl) acrylamide mutagenecity. J Cáncer Res, 1995;86:1131-5.

30. Raresh KT. Herbal medicine in the treatment viral hepatitis. J Gastroenterol, 1999;14(Suppl):A291-A292.

31. Boroliers AT etal. Sho-saiko-to and other Kampo (Japanese herbal) medicine a review of their immunomodulatory activities. J of Ethnopharmacol, 2000;73:1-13.

32. Huacuja L, Delgado NM, Hernández O, Rosado A. Differences in lipoprotein composition between heads and tails of human sperm an infrared spectroscopy study. Arch Androl, 1990;24:17-27.